Skip to content

Enteral Glutamine Supplementation for the Patient With Major Torso Trauma

Early Enteral Glutamine Supplement to Enteral Nutrition Support of the Major Torso Trauma Patient: Proposal for a Prospective Randomized Clinical Trial

Status
Terminated
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00178581
Enrollment
20
Registered
2005-09-15
Start date
2005-06-30
Completion date
2006-09-30
Last updated
2010-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Illness, Shock, Trauma

Keywords

Trauma, Critical Illness, Shock, Enteral Nutrition, Glutamine

Brief summary

Glutamine is considered a conditionally essential amino acid during critical illness. After severe trauma, glutamine supplementation into the gastrointestinal tract may help maintain bowel function. We hypothesize that for the major torso trauma patient, high dose glutamine given enterally during resuscitation from shock and continued during enteral nutrition support is absorbed, available systemically and preserves gut integrity.

Detailed description

In this prospective, randomized, controlled trial of patients with major torso trauma, high-dose enteral glutamine and enteral nutrition will be given to research subjects while controls will receive isocaloric, isonitrogenous enteral support. Enteral tolerance, bowel integrity and permeability will be evaluated. The systemic appearance of glutamine will be measured.

Interventions

DRUGGlutamine

Sponsors

National Institutes of Health (NIH)
CollaboratorNIH
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult trauma patients meeting criteria for shock resuscitation * Major torso trauma * Admission to the Shock/Trauma Intensive Care Unit

Exclusion criteria

* Age \<18 years * Pregnant * Expected survival \< 24 hours * Bowel in discontinuity * Renal failure: baseline serum creatinine\>3.0 and/or dialysis * Admission total bilirubin \>10 mg/dl * History of cirrhosis or cirrhosis apparent on exploratory laparotomy * Asystole or CPR required

Design outcomes

Primary

MeasureTime frame
Gut function

Secondary

MeasureTime frame
Systemic appearance of glutamine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026